Mad in America
OCTOBER 9, 2024
From Science : “In 2016, when the U.S. Congress unleashed a flood of new funding for Alzheimer’s disease research, the National Institute on Aging (NIA) tapped veteran brain researcher Eliezer Masliah as a key leader for the effort. He took the helm at the agency’s Division of Neuroscience, whose budget—$2.6 billion in the last fiscal year—dwarfs the rest of NIA combined.
Harmony United Psychiatric Care
OCTOBER 9, 2024
Neurodevelopmental disorders are characterized by developmental deficits that produce impairments of personal, social, academic or occupational functioning. NDDs may include intellectual disabilities, communication disorders, autistic spectrum disorders (ASD), attention deficit hyperactivity disorder (ADHD), specific learning disorders and motor disorders.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World Psychiatric Association (WPA)
OCTOBER 9, 2024
Onthe 10thofOctober(Thursday), the global community unites once again to celebrate World Mental Health Day (WMHD), an initiative organised by the World Federation for Mental Health(WFMH)and endorsed by the World Health Organization (WHO). This year, the theme focuses on an issue that touches the lives of many Mental Health at Work. With 60% of the global population engaged in some form of employment, the connection between work and mental health is not only significant, but urgent.A healthy, saf
Mad in America
OCTOBER 9, 2024
In this interview, Brooke Siem, who is the author of a memoir on antidepressant withdrawal, May Cause Side Effects , interviews her mother, Dee Barbash, to discuss the circumstances that led to Brooke being prescribed a cocktail of antidepressants at the age of 15. Today, her mother is a therapist who helps her clients taper from psychiatric medications—a profession that she took up after she came to understand the harms that Brooke suffered from having been prescribed these drugs for 15 years.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Expert insights. Personalized for you.
123 
Let's personalize your content